Experiencenew
Branding & Naming Experience
Brand Institute excels as the global leader in brand name and identity development, spanning healthcare, consumer products, and pharmaceutical standards. With over 75% of drug name approvals globally and unparalleled success in consumer and business-to-business branding, it sets the industry benchmark. Additionally, it dominates USAN/INN naming, with significant majorities in drug name approvals worldwide.
1,456
Healthcare Clients
4,777
Total Healthcare Names
1,621
USAN/INN (Nonproprietary)
456
Consumer/B2B Clients
980
Total Consumer/B2B Names
94
Corporate Identities
General Search
Showing 11 - 20 out of 29
Brand | Client | Service | Category |
---|---|---|---|
Lunesta | Waylis Therapeutics | ||
Tezspire | Amgen / AstraZeneca | ||
Lucentis | Genentech | ||
Avastin | Genentech | ||
Hemlibra | Genentech | ||
Tremfya | Johnson & Johnson Johnson & Johnson Innovative Medicine | ||
Imbruvica | Johnson & Johnson Johnson & Johnson Innovative Medicine | ||
Entresto | Novartis | ||
Veganza | BMW | ||
Caplyta | Intra-Cellular Therapies |